Gilead inks another deal with Korean API manufacturer Yuhan, this time worth $140M

Bristol Myers Squibb and Hengrui Pharma signed a massive deal worth up to $15.2 billion. Takeda aims to cut 4,500 jobs in fiscal…

fiercepharma.com5 g fa

Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,

fiercepharma.com3 h fa

The marketing deal is the latest in a series of recent pacts between GSK and China-based drug companies, and could speed access…

biopharmadive.com9 g fa

Strengthening core CDO values for cell line development | Strengthening core CDO values for cell line development

fiercepharma.com9 g fa

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward…

fiercepharma.com5 g fa

As biologics have come to supersede small molecules in the biopharma industry’s pipeline, the mounting complexity behind the…

fiercepharma.com5 g fa

Other newsrooms on this story